Release Date: 29/10/19 08:06 Summary: Appendix 4C and Quarterly Update Price Sensitive: Yes Download Document 394.58KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%